期刊文献+

缬沙坦对高血压病的疗效及其对肱动脉内皮功能的影响 被引量:12

Efficacy of valsartan on essential hypertension and its influence on endothelial function of brachial artery
下载PDF
导出
摘要 目的 :观察缬沙坦对原发性高血压病人的降压疗效及其对肱动脉内皮功能的影响。方法 :35例高血压病病人 (治疗组 )应用缬沙坦 80mg ,po ,qd× 30wk。 2 2例健康志愿者为对照组。采用多普勒超声血管显象法测定 2组肱动脉血流调节的扩血管反应 (FMD)和硝酸甘油诱发的扩血管反应 (NMD)。结果 :治疗组应用缬沙坦后 2wk显著降压 (P <0 .0 1) ,4~ 6wk进一步降压 ,至 30wk持续平稳降压 (P <0 .0 1) ,降压总有效率 2wk为 5 1% ,30wk达 80 % ;治疗组FMD和NMD显著低于对照组[(6±s 5 ) %vs(18± 7) % ,(17± 9) %vs (2 8±11) % ,P <0 .0 1],治疗组应用缬沙坦后FMD与用药前比较显著提高 (P <0 .0 1) ,但仍低于对照组(P <0 .0 1)。结论 :缬沙坦具有降压和改善FMD ,恢复动脉内皮功能 。 AIM: To observe the effect of valsartan on blood pressure and its influence on endothelial function of the brachial artery in patients with essential hypertension (EH). METHODS: The patients with EH (n=35)were treated with valsartan 80mg, qd, for 30 wk. The blood pressure(BP)was measured every 2-4 wk during 30 wk. In EH group (n=35) and control group (n=22), flow-mediated vasodilation (FMD) and nitrogluperin-induced vasodilation (NMD) in the brachial artery were assessed using high-resolution vascular ultrasonic technique. The patients with EH were examined by ultrasonic technique at the end of treatment. RESULTS: At the end of 2 wk, BP decreased significantly in patients with EH treated with valsartan (P< 0.01), further antihypertensive effect was maintained during 4-6 wk, and BP decreased continuously up to 30 wk. The total hypotensive rate of valsartan was 51 % at 2 wk and 80 % at 30 wk respectively. FMD and NMD in treatment group were significantly lower than those in control group ((6±5) % vs (18±7) %, P< 0.01, and (7±9) % vs (28±11) %, P< 0.05). After administration of valsartan, the im-paired FMD restored ((6±5) % vs (10±3) %, P< 0.01), but was lower than that of control group (P<0.01). CONCLUSION: Valsartan has significant effects on antihypertension, improvement of FMD, restoration of artery endothelium and protection from atherosclerosis.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2004年第10期661-663,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 高血压 超声检查 多普勒 彩色 内皮 血管 缬沙坦 血管内皮功能 hypertension ultrasonography,doppler,color endothelium, vascular valsartan vascular endothelial function
  • 相关文献

参考文献3

二级参考文献8

  • 1[1]THRMANN PA. Angiotensin II antagonism and the heart: valsartan in left ven tricular hypertrophy [J]. J Cardiovasc Pharmacol ,1999, 33 Suppl 1:S33-S36.
  • 2[2]PLUM J, BNTEN B, N**METH R, et al. Effects of the angiotensin II ant agonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients wit h chronic renal failure and hypertension [J]. J Am Soc Nephrol, 1998, 9(12): 2 223-2234.
  • 3[3]BREMNER AD, BAUR M, ODDOU-STOCK P, et al. Valsartan: long term effica cy and tolerability compared to lisinopril in elderly patients with essential hypertens ion [J]. Clin Exp Hypertens, 1997, 19(8): 1263-1285.
  • 4[4]MARKHAM A, GOA KL. Valsartan a review of its pharmacology and therapeutic use in essential hypertension [J]. Drugs ,1997 ,54(2): 299-311.
  • 5[5]BLACK HR, GRAFF A, SHUTE D, et al. Valsartan, a new angiotensin II ant agonis t for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril [J]. J Hu m Hypertens, 1997,11(8): 483-489.
  • 6庄汉屏,余国龙,廖锦堂,王振华.肱动脉血管超声运动试验对冠心病硝酸酯类耐药性评价[J].中华心血管病杂志,1998,26(5):371-373. 被引量:12
  • 7赵铁军.血管内皮功能障碍及其治疗进展[J].国外医学(心血管疾病分册),1999,26(2):70-73. 被引量:19
  • 8邓家强.氯沙坦治疗充血性心力衰竭及对血浆内皮素和醛固酮的影响[J].中国新药与临床杂志,2002,21(1):19-21. 被引量:12

共引文献50

同被引文献89

引证文献12

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部